SUBSCRIBE
SUBSCRIBE
News   FDA

UCB, Inc. Says Keppra XR Epilepsy Drug Approved in U.S.

September 15, 2008 | 
1 min read
BRUSSELS, Sept 15 (Reuters) - Belgian pharma group UCB said on Monday that U.S. health authorities had approved epilepsy drug Keppra XR and that it would go on sale just before its mother drug loses patent protection.
FDA Approvals Europe
MORE ON THIS TOPIC
Adults hand drawing pathway for baby boy. Parent influence on child development and future. Parental control and support for growth and education of kid. vector
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
March 24, 2026
 · 
3 min read
 · 
Heather McKenzie
Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
March 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman confuse others with jargon in speech bubble dialogue
FDA
9 Months In, FDA’s New Priority Voucher Program Still Clouded With Uncertainty
March 23, 2026
 · 
7 min read
 · 
Heather McKenzie
Illustration of businessman with flag looking victorious on top of teetering blocks
Approvals
Rhythm Bounces Back from Phase 3 Fail with FDA Nod for Rare Obesity Injection
March 20, 2026
 · 
2 min read
 · 
Tristan Manalac